ReviewFrontiers in oncology2022

Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials.

Qionglian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.